Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Progyny, Inc. (PGNY)

30.60 +0.38 (+1.26%)
As of 3:32:33 PM EDT. Market Open.
Trade Progyny on Coinbase
Chart Range Bar
Loading chart for PGNY
  • Previous Close 30.22
  • Open 30.22
  • Bid 22.17 x 200
  • Ask 38.77 x 200
  • Day's Range 29.99 - 31.07
  • 52 Week Range 16.10 - 31.07
  • Volume 1,074,568
  • Avg. Volume 1,535,083
  • Market Cap (intraday) 2.397B
  • Beta (5Y Monthly) 1.02
  • PE Ratio (TTM) 39.74
  • EPS (TTM) 0.77
  • Earnings Date (est.) Aug 6, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 30.09

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

www.progyny.com

835

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Performance Overview

Trailing total returns as of 7/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PGNY
19.16%
S&P 500 (^GSPC)
10.28%

1-Year Return

PGNY
42.59%
S&P 500 (^GSPC)
20.22%

3-Year Return

PGNY
17.32%
S&P 500 (^GSPC)
71.12%

5-Year Return

PGNY
50.27%
S&P 500 (^GSPC)
73.81%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 328.5M
Earnings 42.01M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
100M
200M
300M

Analyst Insights

View More

Analyst Price Targets

27.00 Low
30.09 Average
30.60 Current
33.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/22/2026
Analyst Truist Securities
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 30 -> 33

Statistics

View More

Valuation Measures

Annual
As of 7/2/2026
  • Market Cap

    2.37B

  • Enterprise Value

    2.17B

  • Trailing P/E

    39.27

  • Forward P/E

    14.97

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.07

  • Price/Book (mrq)

    5.39

  • Enterprise Value/Revenue

    1.68

  • Enterprise Value/EBITDA

    21.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.23%

  • Return on Assets (ttm)

    9.12%

  • Return on Equity (ttm)

    14.94%

  • Revenue (ttm)

    1.29B

  • Net Income Avi to Common (ttm)

    67.69M

  • Diluted EPS (ttm)

    0.77

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    225.11M

  • Total Debt/Equity (mrq)

    6.21%

  • Levered Free Cash Flow (ttm)

    200.21M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

30.60 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • PROGYNY INC has an Investment Rating of BUY; a target price of $32.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    PROGYNY INC has an Investment Rating of BUY; a target price of $32.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
  • PROGYNY INC has an Investment Rating of BUY; a target price of $29.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    PROGYNY INC has an Investment Rating of BUY; a target price of $29.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
  • PROGYNY INC has an Investment Rating of BUY; a target price of $29.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    PROGYNY INC has an Investment Rating of BUY; a target price of $29.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
  • PROGYNY INC has an Investment Rating of BUY; a target price of $28.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    PROGYNY INC has an Investment Rating of BUY; a target price of $28.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: